Arizona Biosciences News
Covance selects new Chandler site
Global drug-development services company Covance Inc. has announced that its planned research facility in Chandler has been moved to a new location.
The company now plans to build on 50 acres to the east of Chandler Municipal Airport, an area already approved for an industrial facility.
Covance is one of the largest drug development services companies in the world, boasting annual revenues exceeding $1 billion, operations in over 20 countries, and more than 7,500 employees worldwide.
Barry Broome, president and chief executive officer for the Greater Phoenix Economic Council, told Arizona Republic that Covance's commitment to build in Chandler "is critical to the future of this region."
Covance had previously planned to build along the Price corridor in Chandler and had purchased a site that required rezoning from agricultural to industrial. The company, which uses animals in federally required clinical trials of drugs, has been the target of animal rights protestors who hoped to prevent a successful rezoning bid.
The original plan included up to 591,000 square feet of laboratories, offices, conference rooms, and employee amenities, including room for expansion and 1,200 jobs. The first phase of the new plan will involve 300,000 square feet and eventually up to 2,000 employees.
Wendel Barr, president of early development for Covance, told Arizona Republic that the company is still in the process of buying the new site, which is owned by Chicago-based First Industrial Services Inc.
The company still needs to obtain permits and has not yet announced when it will start construction.
For more information:
"Covance headed to Valley," Arizona Republic, 10/04/2006
"Covance changing sites for planned laboratory," East Valley Tribune, 10/04/2006
""Covance drug development center could employ 2,000," Business Journal, 10/02/2006